Health-tech platform RedBrick AI has scooped up a $4.6 million seed funding round led by Sequoia India and Southeast Asia’s Surge along with participation from Y Combinator and other angel investors.
RedBrick AI was backed by Y Combinator as part of the W22 batch. The proceeds will be utilised to strengthen the engineering team in India, expand the suite of products, and power the next generation of researchers in building AI for clinical settings, CEO Shivam Sharma said in a press release.
About RedBrick AI
RedBrick AI co-founder and CEO Shivam Sharma said the startup helps make annotations up to 60% faster using its configurable workflow system that works with medical imagery such as CT scans, X-rays, MRIs and ultrasound.
“We see ourselves building the foundational layer of artificial intelligence in healthcare. In the future, we want to help teams with everything from the data preparation to FDA clearance of the algorithms,” Sharma said in an interview with TechCrunch.
RedBrick AI has a seven-member team that is mostly based in India, though the startup focuses primarily on the U.S. and Europe for marketing its tools. The startup also sees 99% of competition coming from open-source tools, followed by the in-house ones developed by companies to address their specific requirements.
The early customer base of RedBrick AI includes Germany’s biotech startup Orbem, Canada’s cancer and disease screening platform Prenuvo, Boston-based non-profit hospital and physician network Mass General Brigham and Maharashtra’s radiology AI platform Deeptek.